N. Lomborg

Level of Adherence to Prophylactic Osteoporosis Medication amongst Patients with Polymyalgia Rheumatica and Giant Cell Arteritis: A Cross-Sectional Study

A. Emamifar, R. Gildberg-Mortensen, S. Andreas Just, 2015, International journal of rheumatology.

Retroperitoneal fibrosis as the presenting manifestation of IgG4-related disease in a patient previously diagnosed with granulomatosis with polyangiitis (Wegener’s): one disease or two?

N. Marcussen, P. Junker, N. Lomborg, 2014, Scandinavian journal of rheumatology.

Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease: clinical outcomes in real-world patients from the DANBIO registry

A. Loft, J. K. Pedersen, F. Mehnert, 2022, RMD Open.

Comparative effectiveness of two adalimumab biosimilars in 1318 real-world patients with inflammatory rheumatic disease mandated to switch from originator adalimumab: nationwide observational study emulating a randomised clinical trial

A. Loft, J. K. Pedersen, F. Mehnert, 2021, Annals of the Rheumatic Diseases.

Level of Adherence to Prophylactic Osteoporosis Medication amongst Patients with Polymyalgia Rheumatica and Giant Cell Arteritis: A Cross-Sectional Study

A. Emamifar, Jensen Hansen, I. Marie, 2015, International journal of rheumatology.

IgG4-related disease in patients with newly diagnosed idiopathic retroperitoneal fibrosis: a population-based Danish study

P. Junker, M. Jakobsen, N. Lomborg, 2019, Scandinavian journal of rheumatology.